The specialized metabolism and trafficking of cellular subcompartments
Your first biology course probably defined eukaryotes in part as having a group of specialized organelles. These membrane-bound subcompartments of the eukaryotic cell are unique in many ways, especially their specialized biochemistry and metabolism.
The three sessions we have organized for Discover BMB will cover several topics focused on the novel biology and biochemistry of the mitochondria, peroxisome and chloroplast. These sessions will address current research on specific metabolic pathways, with important new insights into the protein structure and trafficking that support the integrity and function of these organelles.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
These multidisciplinary talks will provide information not only on the specific biochemical functions of these organelles, but also on their integrative architecture and physiology. In the three sessions, new information will be integrated into general principles of organelle biogenesis and metabolic function.
Keywords: Mitochondria, chloroplast, peroxisome, metabolism, covalent modifications, organelle biogenesis, protein structure and trafficking.
Who should attend: Anyone interested in metabolism, organellar proteomes and the specialized biology of organelles.
Theme song: “The Cell” by Gojira, because it is such a high-energy song — mitochondria, chloroplasts ...
This session is powered by ATP.
Mitochondria, peroxisomes and chloroplast metabolism

Protein covalent modifications and chloroplast metabolism
Chair: Greg Moorhead
Greg Moorhead, University of Calgary
Glen Uhrig, University of Alberta
R. Paul Jarvis, University of Oxford
Paula Mulo, University of Turku
Peroxisome biogenesis/metabolism
Chair: Tom Rapoport
Francesca Di Cara, Dalhousie University
Brooke Gardner, University of California, Santa Barbara
Tom Rapoport, Harvard Medical School; Howard Hughes Medical Institute
Irfan Lodhi, Washington University in St. Louis
Mitochondria energetics/metabolism
Chair: Erin Goley
Pere Puigserver, Dana–Farber Cancer Institute; Harvard Medical School
Lena Pernas, Max Planck Institute for Biology of Ageing
Alexey Amunts, Stockholm University
Rebecca Voorhees, California Institute of Technology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Sizing up cells: How stem cells know when to divide
Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.

When oncogenes collide in brain development
Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.

The data that did not fit
Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.